A Phase I Clinical Trial of an HPV Therapeutic Vaccine
Latest Information Update: 03 Oct 2021
Price :
$35 *
At a glance
- Drugs Human papillomavirus E6 protein inhibitors (Primary) ; Candida antigen
- Indications Cervical intraepithelial neoplasia; Squamous cell cancer
- Focus Adverse reactions
- 05 Jun 2018 Results (n=34) assessing cervical microbiome role in outcomes of therapeutic HPV vaccination for cervical intraepithelial neoplasia, were presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
- 15 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Aug 2012 New trial record